Analyst Reco. Anterix Inc.

Equities

ATEX

US03676C1009

Market Closed - Nasdaq Other stock markets 01:00:00 2024-07-03 pm EDT			5-day change	1st Jan Change
38.86 ^USD	-0.82%		+24.35%	+16.63%

Jun. 27	Transcript : Anterix Inc., Q4 2024 Earnings Call, Jun 27, 2024
Jun. 26	Earnings Flash (ATEX) ANTERIX Reports Q4 Loss $-0.51	MT

Analyst Reco.

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Morgan Stanley Adjusts Price Target on Anterix to $41 From $42, Maintains Equal-Weight Rating	23-08-01	MT
Morgan Stanley Adjusts Price Target on Anterix to $42 From $63, Maintains Equal-Weight Rating	23-02-24	MT
Morgan Stanley Adjusts Anterix's Price Target to $63 from $65, Maintains Equalweight Rating	22-02-10	MT
Berenberg and Goldman Sachs German Corporate Conference	21-09-20	FA
ANTERIX : Morgan Stanley Adjusts Price Target on Anterix to $65 From $51, Maintains Equal-Weight Rating	21-08-04	MT
ANTERIX : JPMorgan Adjusts Price Target on Anterix to $60 From $50, Maintains Overweight Rating	21-06-17	MT
ANTERIX : Morgan Stanley Adjusts Price Target on Anterix to $51 From $48, Maintains Equal-Weight Rating	21-06-09	MT
ANTERIX : JPMorgan Upgrades Anterix to Overweight From Neutral, Adjusts Price Target to $50 From $40	21-02-17	MT
ANTERIX : JPMorgan Upgrades Anterix to Neutral From Underweight, Adjusts Price Target to $40 From $30	21-02-01	MT
ANTERIX : Morgan Stanley Adjusts Price Target on Anterix to $48 From $50, Maintains Equal-Weight Rating	21-01-27	MT
ANTERIX : JP Morgan Downgrades Anterix to Underweight from Neutral, Lowers PT to $30 From $58	20-11-18	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Protect and grow your investments with the help of our experts

Securing my Investments

fermer